Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Kolovrat M, Gojkovic S, Krezic I, et al
95% CI, 1.01 to 6.73
At 96 weeks, Vijiaratnam and colleagues reported that MDS-UPDRS III off-medication scores increased by a mean of 5.7 points in the exenatide group and 4.5 points in the placebo group
Integrating UGT inhibition data into the rule-of-two model significantly enhances the prediction accuracy for drug-induced liver injury (DILI) (119)
Stopping semaglutide can lead to a range of effects, including an increase in weight
About this article Cite this article Al-Hetty, H.R.A.K., Abdulameer, S.J., Alghazali, M.W
US$ 27.97
US$ 20.66
US$ 25.52
US$ 28.36
US$ 28.00
